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Functional Flexibility in T Cells:
Independent Regulation of CD41 T Cell
Proliferation and Effector Function In Vivo
cells were able to cycle; thus, it was difficult to be certain
whether cells express effector cytokines after several
divisions because of constraints imposed by the cell
cycle, or whether proliferation and differentiation simply
occurred in parallel.
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This point is important because a tight linkage be-
tween proliferation and function is compatible with some
Summary models of differentiation but not with others. In particu-
lar, this interpretation is hard to reconcile with the idea
Proliferation and differentiation of CD41 T cells are that cytokine gene activation is stochastic (Kelso et al.,
often correlated, but it is not clear whether they are 1995), which is an attractive hypothesis to explain the
mechanistically linked. When antigen-specific T cells observed monoallelic expression of many cytokine
are present at high frequency in vivo, they all respond genes (Shulman et al., 1999). If these genes were turned
to antigenic peptide stimulation by expressing activa- on at low frequency and at random, it would follow
naturally that in most T cells, only one locus would betion markers, but only a subset begins to proliferate.
active.However, noncycling cells may synthesize the effector
One way to test these ideas is to examine T cellscytokine IFNg even though their cell cycle is blocked
responding in vivo under conditions where a subset ofin G1. These data show that proliferation and effector
the T cells does not divide. To achieve this, we con-function are not rigidly linked in T cells. Instead, CD41
structed chimeric mice with a variable frequency of Ag-T cells have the flexibility to engage in or bypass clonal
specific precursor cells, including frequencies highexpansion based on the integration of multiple signals,
enough to impose constraints on proliferation. We usedincluding the frequency of other responding T cells.
reconstitution of irradiated hosts with T-depleted bone
marrow so that the antigen-specific T cells could differ-
entiate and be exported from the thymus normally andIntroduction
would be present in the periphery as naive precursors.
Thus, the T cells were not subject to handling nor adop-The clonal selection theory predicts that antigen (Ag)-
tive transfer prior to the experiment. This protocol avoidsspecific clonal expansion is required to increase the
any changes that might be induced in the T cells by afrequency of rare precursor T cells (Burnet, 1957). Direct
transfer, for example, antigen-independent proliferationevidence for this comes from studies of normal T cells
that would be expected to occur following the introduc-responding to superantigens (MacDonald et al., 1990;
tion of mature T cells into lymphopenic hosts (Rocha etWebb et al., 1990; Herman et al., 1991; Kawabe et al.,
al., 1989).1991) and T cell receptor (TCR) transgenic mice re-
Using this model, we reexamined the role of cell cyclesponding to the infusion of antigenic cells or antigenic
constraints in the induction of effector cytokine expres-peptides (Rocha et al., 1991; Moskophidis et al., 1993;
sion, looking specifically at IFNg in noncycling Ag-spe-McHeyzer-Williams and Davis, 1995). However, TCR li-
cific CD41 T cells. The data show that proliferation andgation does not invariably result in clonal expansion.
the delivery of effector function are uncoupled in vivo.In many TCR transgenic mice with a high frequency
Some T cells became activated, underwent G1 arrest,(30%–80%) of Ag-specific T cells, TCR ligation causes
and did not proliferate at any time during the experiment,only weak proliferation (Huang et al., 1994; Liblau et al.,
yet these cells were fully competent to synthesize the1996; Pearson et al., 1997; Chen et al., 1998).
effector cytokine IFNg. This is fully compatible with theIn vivo clonal expansion transforms rare cells with a
idea of stochastic cytokine gene expression but incom-naive phenotype into abundant cells with an activated
patible with models in which a cycle-counting mecha-phenotype. But are cell division and maturation simply
nism controls cytokine synthesis.correlated, or is differentiation mechanistically linked to
proliferation? Differentiated CD41 T cells exhibit hetero-
Resultsgeneous patterns of cytokine expression, resulting in at
least two distinct cell subsets: Th1 cells that produce
IFNg and lymphotoxin and Th2 cells that produce IL-4, Bone Marrow Chimeras with Variable Frequency
of Ag-Specific T CellsIL-5, and IL-13 (Mosmann et al., 1986). Recent analysis
of the process of T cell proliferation and differentiation We constructed bone marrow (BM) chimeras in which
the donor marrow was a mixture of TCR transgenic BMin culture showed that IL-2 expression was cell cycle
independent, while the effector cytokines IFNg and IL-4 from Rag-2-deficient mice with an I-Ek-restricted Va11,
Vb3 TCR specific for a pigeon cytochrome c (PCC) pep-were only expressed in cells that had undergone several
divisions (Bird et al., 1998; Gudmundsdottir et al., 1999; tide, and nontransgenic BM. TCR transgenic donor mice
were Thy-1.2, and nontransgenic donor mice were Thy-Richter et al., 1999). In these experiments, all of the T
1.1; this was used to identify the two sets of T cells.
Six groups of chimeras were constructed containing* To whom correspondence should be addressed (e-mail: nick_
0%, 1%, 10%, 50%, 90%, and 100% of TCR transgeniccrispe@urmc.rochester.edu).
BM cells (Figure 1). These chimeras were studied 4† Present address: University of Rochester, Center for Vaccine Biol-
weeks after BM injection, which was the time of optimalogy and Immunology, 601 Elmwood Avenue, Box 609, Rochester,
New York 14642. T cell reconstitution in preliminary kinetic experiments
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the frequency of cycling cells was determined by in vivo
incorporation of 5-bromo-2-deoxyuridine (BrdU) (Figure
2A). Our protocol was optimized to detect all cells that
have entered cell cycle in vivo, and our internal controls
show that BrdU was not limiting. Thus, 30%–50% of
thymocytes were labeled, and this is a higher percent-
age of a larger total number of cells (150 3 106) than we
needed to label in the lymph nodes. Also, the technique
showed a clear separation between positive and nega-
tive cells with very few BrdU-low cells, which we would
expect to see if BrdU was limiting. In additional control
experiments, we used BrdU labeling versus staining for
DNA content to show that all of the cells in S phase
were in fact labeled with BrdU.
In this study, proliferation was measured after 3 days
of regular BrdU injection, which was the time of greatest
accumulation of BrdU1 cells in preliminary kinetic exper-
iments (data not shown). Only 2%–5% of control non-
transgenic T cells incorporated BrdU in peptide-treated
mice, similar to PBS-treated mice. In contrast, 35%–
100% of Ag-specific T cells were BrdU1. This prolifera-
tion was specific for PCC stimulation since PBS injection
was without effect. At a high frequency of Ag-specific
cells (90%), the BrdU1 T cells were 45% of the total
CD41Va111 cell subset. In contrast, at low frequency
(5%) almost all of the TCR transgenic T cells were BrdU1
(97%). Thus, the relationship between the abundance
of naive CD41Va111 cells and their potential for clonal
expansion was inverse. While the absolute number of
BrdU1CD41Va111 cells increased with the number of
TCR transgenic cells, the chimeras with the most TCR
transgenic cells did not show a proportional increase.
Instead, the number of BrdU1 cells appeared to be asymp-
totically approaching an absolute upper limit of around
8 3 106 cells (Figure 2B). To test whether the inverse
relationship between precursor frequency and cycling
was unique to the response to specific peptide, the
response to an exogenous superantigen, Staphylococ-
cal enterotoxin A (SEA), was analyzed in the same set
of chimeras. This superantigen activates specifically T
cells expressing Vb3 (Dohlsten et al., 1993) and thus the
TCR transgenic cells. An inverse relationship between
the precursor frequency and the rate of T cell prolifera-
tion was observed following SEA stimulation (Table 1).Figure 1. Predictable Expression of a Va111 Transgenic TCR in Ra-
Thus, the precursor T cell frequency constrains prolifer-diation Chimeras Reconstituted with Different Proportions of TCR
ation, whatever the antigenic stimulus.Transgenic (Thy-1.21) and Nontransgenic (Thy-1.11) Bone Marrow
DC were present at a normal frequency (2%–4%) inData are from one representative experiment of ten with three mice/
the lymph nodes of all chimeras. To test whether thegroup/experiment.
DC were limiting for the activation of T cells at high
frequency, we treated mice with fms-like tyrosine ki-
nase-3 (Flt-3) ligand (Flt-3L), a cytokine that increases(data not shown). In all chimeras, the dendritic cells (DC,
the number of functionally mature DC (Maraskovsky etdefined as CD11c1 MHC IIhigh) were 2%–3%, the B cells
al., 1996). Three groups of chimeras containing 5%,(B2201) were 25%–30%, and the total T cells (TCRab1)
45%, and 90% TCR transgenic cells were subcutane-were 65%–70% . Using both Thy-1.2 and TCR Va11
ously injected for 9 days with Flt-3L, causing at least amarkers (Figure 1), the frequency of Ag-specific T cells
6-fold expansion of DC in lymph nodes (Figure 2C). Onwas predictably determined by the frequency of trans-
the final day of Flt-3L treatment, chimeras were injectedgenic BM cells, although this relationship was not strictly
with the specific peptide and BrdU as described above.linear. These mice contained within the T cell compart-
The increase in DC number did not result in any increasement 0%, 0.5%, 5%, 45%, 90%, or 100% of CD41
in the frequency of cycling CD41Va111 cells, and theThy1.21Va111 cells.
inverse relationship between T cell frequency and clonal
expansion was not affected. Thus, the constraint on
Generation of Noncycling Ag-Specific T Cells upon clonal expansion in CD41 T cells at high frequency was
In Vivo Stimulation of T Cells at High Frequency not due to limiting numbers of professional antigen-
Chimeras with a high (90%) versus low (5%) frequency presenting cells. To show that DC from Flt-3L-treated
of Ag-specific T cells were stimulated in vivo by injection chimeras were fully functional, 105 such cells or an equal
number of DC isolated from normal mice were pulsedof PCC peptide as described by Kaye et al. (1989), and
Functional Flexibility in T Cells
293
Figure 2. Constraints on T Cell Proliferation In Vivo
(A) Selective gates on TCR transgenic or nontransgenic cells in chimeras with a high (a) or low (b) frequency of TCR transgenic cells show
that when T cells are abundant a subset proliferates (40% BrdU positive, in the example shown). When T cells are rare, all proliferate (97%).
Nontransgenic cells show only background proliferation.
(B) The frequency of proliferating cells (a) is inversely related to the TCR transgenic cell number, while the absolute number of proliferating
cells (b) is positively correlated with cell number but approaches a limit of around 8 3 106 cells.
(C) The TCR transgenic T cell number does not affect the number of DC ([a], closed circles). Treatment with Flt-3L increases the DC number
around 5-fold in all groups of chimeras ([b], closed squares), but there is no effect on the inverse relationship between the number of TCR
transgenic cells and the frequency of proliferating cells (compare [a] with [b], open symbols). Results represent the mean value for four mice
per group.
with PCC peptide in vitro and injected into chimeras Noncycling Ag-Specific T Cells Are Phenotypically
Similar to Cycling Cellscontaining 90% of transgenic T cells. Both populations
of DC resulted in BrdU incorporation in z50% of TCR As a proportion of Ag-specific T cells did not proliferate
in response to specific peptide, we next asked whethertransgenic cells 3 days later, showing that the Flt-3L-
expanded DC were equally potent on a per cell basis. these noncycling T cells expressed activation markers
Table 1. In Vivo T Cell Proliferation Induced by SEA Stimulation
Percentage of
CD41Va111 Cells Percentage of Percentage of Percentage of
in Chimeras BrdUrda Day 0 BrdUrd/PBSb Day 3 BrdUrd/SEAc Day 3
90 6 7.1 1.3 6 0.9 2.8 6 0.9 45 6 8.9
25 6 4.1 1.9 6 0.5 3.4 6 1.2 76 6 11
3 6 1.3 2.2 6 1.2 1.8 6 1.0 93 6 5.2
a Percentages of BrdUrd1 cells gated on CD41Va111 cells from untreated mice.
b Percentages of BrdUrd1 cells gated on CD41Va111 cells from PBS-treated mice.
c Percentages of BrdUrd1 cells gated on CD41Va111 cells from SEA-treated mice.
Values represent the mean 6 SE of the data from four separate experiments.
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Figure 3. Noncycling Ag-Specific T Cells
Show Phenotypic Changes of Activated T
Cells
In saline (PBS)-injected control chimeras,
nontransgenic T cells mostly expressed a na-
ive phenotype, while TCR transgenic CD41
Va111 cells exclusively expressed a naive
phenotype. Compare, in particular, CD44 and
CD62L expression in the two PBS-treated
groups. In PCC peptide–injected chimeras
containing 90% of TCR transgenic cells, cy-
cling and noncycling CD41-Va111 cells were
analyzed for activation markers on day 3.
Data are from one representative experiment
of five with two mice/group/experiment.
associated with TCR signaling. Naive T cells are negative The vast majority (80%) of both cycling and noncycling
Ag-specific T cells were CD691. This expression peakedfor CD69 expression and express a low density of CD44
but a high density of CD62L. Following encounter with on day 2 and was downregulated after day 4, a transient
pattern that has been described before (Testi, 1994).antigen, the phenotype changes to CD691CD44high
CD62Llow (Budd et al., 1987; Testi., 1994; Tripp et al., In our chimeras, the fluctuations in CD69 expression
suggested that the noncycling Ag-specific T cells were1995). Without stimulation, Ag-specific T cells had the
typical phenotype of naive T cells, CD691CD44low antigen experienced. In addition, expression of CD44
and CD11a was upregulated and expression of CD62LCD62Lhigh, which was also the phenotype of nontrans-
genic bystander cells in the chimeras (compare the two and CD49d was downregulated, and these effects were
the same on both cycling and noncycling T cells. Thus,columns marked “PBS” in Figure 3). Close inspection
of the data reveals that theVa111 cells displayed a more activation was not always associated with T cell prolifer-
ation. Some of these data are difficult to reconcile withuniform naive phenotype than the nontransgenic cells
with essentially no CD44-high nor CD62L-low cells. This previous work, which argued that upregulation of CD44
and downregulation of CD62L were dependent on cellwas to be expected, since a subset of the nontransgenic
cells are likely to have responded to environmental anti- cycle progression (Gudmundsdottir et al., 1999). How-
ever, the data in this study actually show downregulationgens, while the TCR transgenic Va111 cells would not
have done so. After in vivo stimulation, both cycling of CD62L before the first cell division and, thus, that the
link between cell cycle and phenotype is not absolute.and noncycling Ag-specific T cells showed phenotypic
changes characteristic of TCR engagement (the two col- Our results go further and show that activation of resting
naive CD41 T cells in vivo occurred quite independentlyumns marked “Peptide” in Figure 3), while nontrans-
genic Va11-negative cells retained the naive phenotype. from cell cycle progression.
Functional Flexibility in T Cells
295
cells as well as in nontransgenic CD41Va112 cells, there
was low expression of cyclin A (MFI 60 and 45, respec-
tively). High expression of cyclin D3 was found in large
(MFI 1100) and small (MFI 960) CD41Va111BrdU1 cells
as well as in CD41Va111BrdU2 cells (MFI 920). However,
low levels were found in nontransgenic CD41Va112 (MFI
230) cells. In summary, the expression of these two
cyclins shows that the uninvolved bystander cells were
in G0 phase, while the proliferating cells were mostly
in S, G2, or M phase. Significantly, the noncycling but
phenotypically activated cells expressed high levels of
cyclin D3 but not cyclin A. These data strongly suggest
that these noncycling transgenic CD41Va111 T cells
were arrested in G1 phase.
The cyclin-dependent kinase (cdk) inhibitor p21cip-1 neg-
atively regulates the entry of cells into S phase and is
upregulated in quiescent and senescent cells (Harper et
al., 1993) and was thus a strong candidate for the G1
arrest we observed. However, no significant difference in
p21cip-1 expression was observed in any cell population.
Low levels of p21cip-1 were expressed in nontransgenic
CD41Va112 cells (MFI 19) as well as in noncycling trans-
genic CD41Va111 (MFI 21) and in cycling transgenic
CD41Va111 (MFI 21–33) cells. Similarly, there was a low
level of protein expression of the cell cycle inhibitor p53
(Braithwaite et al., 1987). As an additional control, the
Figure 4. Noncycling Ag-Specific Cells Show Cell Cycle Arrest in G1 expression of a constitutive cell cycle control protein,
Cycling and noncycling CD41Va111 cells generated upon PCC stim- cdk-2 (Draetta et al., 1988), was similar in all cell popula-
ulation in chimeras containing 90% of TCR transgenic cells were tions (data not shown). We therefore conclude that the
analyzed for expression of cell cycle control proteins on day 3. The differences we observed in cyclins A and D3 are specific.
data show cytoplasmic staining for cyclin A, cyclin D3, p21cip-1,
and an isotype-matched IgG control. The cell populations shown
are control nontransgenic T cells (dotted lines), TCR transgenic Noncycling Ag-Specific T Cells Are Able
BrdU1 large blast cells (thin solid lines), TCR transgenic small BrdU1 to Express IFNg
cells (dashed lines), and the TCR transgenic but BrdU negative cells Entry into the cell cycle has been proposed to be a neces-
(thick solid lines). The data show that the noncycling TCR transgenic sary and indispensable component of T cell differentiation
cells contain elevated cyclin D3 but not cyclin A; therefore, they are (Bird et al., 1998). In an in vitro model, the expression of
in G1 phase of the cycle. Data are from one representative experi-
IL-2 was cycle independent, whereas effector cytokinement of three with two mice/group/experiment.
expression was cycle dependent. As a proportion of Ag-
specific T cells did not proliferate in response to in vivo
stimulation, we were able to test whether these Ag-experi-
enced noncycling CD41 T cells were capable of expressingIdentification of the Cell Cycle Stage at which
the Noncycling Ag-Specific T Cells Arrest effector cytokines. Lymph node T cells from chimeras
containing 90% TCR transgenic cells were restimulatedWe next asked whether the noncycling but activated
cells were arrested in cycle (i.e., in the G1 phase) or in vitro for 5 hr with phorbol myristic acetate (PMA) and
ionomycin, and the frequency of cytokine-secreting cellswere similar to noncycling resting cells (i.e., in G0 phase).
To determine this, we analyzed expression of proteins was determined by flow cytometry (Figure 5). The cytokine
production measured in these experiments specificallyinvolved in cell cycle progression (Figure 4). Lymph node
cells were stained for CD4 and Va11 expression, then reflects T cells primed by prior encounter with antigen, as
naive Ag-specific T cells isolated from PBS-treated micepermeabilized and stained for BrdU incorporation and
the presence of cell cycle control proteins. Figure 4 exhibited no cytokine production during the assay period
(data not shown).shows the expression of three cell cycle control proteins
in large-sized CD41Va111 BrdU1 blast cells (thin solid T cells isolated from peptide-treated mice showed
that a large fraction of both cycling and noncyclinglines), smaller CD41Va111BrdU1 cells (dashed lines),
and the phenotypically activated but noncycling BrdU- CD41Va111 cells as well as a small proportion of
CD41Va112 cells (almost all noncycling cells) expressednegative CD41 Va111 cells (thick solid lines). As an inter-
nal control, we gated on nontransgenic CD41Va112cells IL-2. This is consistent with the fact that IL-2 may be
expressed by both naive and activated/memory T cells(Figure 4, dotted lines).
Expression of different cyclins occurs at specific (Tanchot et al., 1998) and by both cycling and noncycling
T cells (Bird et al., 1998; Gumundsdottir et al., 1999;stages of the cell cycle. We examined the expression
of cyclin A, which is synthesized in S, G2, and M (Pagano Richter et al., 1999). The frequency of IL-21 cells was
10-fold higher in Ag-specific CD41Va111 (BrdU1 andet al., 1992), and cyclin D3, which reaches a maximum
level in G1 phase, remains elevated through the rest of BrdU2) cells than in CD41Va112 bystander cells. Impor-
tantly, analysis of effector cytokine expression showedthe cell cycle, and acts specifically in mid-G1 (Baldin et
al., 1993). We observed high levels of cyclin A in large clear evidence of IFNg in the absence of cell cycle pro-
gression. Noncycling activated CD41Va111 cells ex-(mean fluorescence index [MFI] 200) and small (MFI 180)
CD41Va111BrdU1 cells. However, in CD41Va111BrdU2 pressed IFNg at a frequency and intensity similar to, if
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Cycling and Noncycling Ag-Specific T Cells Have
Distinct Migration Patterns toward ELC
and SLC Chemokines
CCR7, a ligand for the secondary lymphoid tissue che-
mokine (SLC) and for Epstein-Barr virus–induced mole-
cule 1 ligand chemokine (ELC), is constitutively ex-
pressed on naive T cells and lost upon differentiation
to effector cells (Yoshida et al., 1997). Compared to
CCR71 T cells, CCR72 T cells have been reported to
undergo a larger number of divisions (Sallusto et al.,
1999). To test whether migration induced through CCR7
is linked to cell cycle progression, cycling and noncy-
cling Ag-specific cells were tested for chemotactic ac-
tivity toward SLC and ELC chemokines in a transwell
filter migration assay (Figure 6).
Some investigators reported that SLC and ELC che-
mokines attract naive but not activated T cells (Gunn et
al., 1998; Ngo et al., 1998; Potsch et al., 1999), while
others reported the opposite (Willimann et al., 1998;
Yoshida et al., 1998; Sallusto et al., 1999). We found
SLC and ELC chemokines highly active on Ag-specific
T cells isolated from peptide-treated chimeras (Figure
6A, closed symbols), while Ag-specific T cells isolated
from PBS-treated mice showed only a weak migration
toward these chemokines (Figure 6A, open symbols).
Our results support the finding that activated T cells
are preferential targets for SLC and ELC chemotactic
activity. Furthermore, cycling and noncycling Ag-spe-
cific cells were differentially attracted by SLC and ELC
chemokines. The starting population of Ag-specific cells
was 50% cycling cells and 50% noncycling cells. Ag-
specific cells that migrated through a 5 mm pore
transwell filter toward either SLC or ELC consisted of
only 18%–21% cycling cells. Thus, noncycling Ag-spe-
cific cells preferentially migrated toward these chemo-
kines. Our results suggest a negative correlation be-
tween migration induced through CCR7 receptor and
Ag-specific clonal expansion.
Discussion
What Limits Clonal Expansion?
This study shows that the magnitude of Ag-specificFigure 5. Noncycling Ag-Specific Cells Are Able to Express Effector
clonal expansion of CD41 T cells is inversely propor-Cytokines
tional to the frequency of naive T cells. Although super-Cycling and noncycling CD41Va111 cells in chimeras containing
antigens interact with class II MHC molecules and TCRs90% of TCR transgenic cells were analyzed for intracellular expres-
differently from peptides (Webb et al., 1994), we foundsion of effector cytokines. On day 3 after PCC/BrdU injections, trans-
that when T cells were stimulated with SEA instead ofgenic (CD41Va111) and nontransgenic (CD41Va112) cells were ana-
antigenic peptide, the inverse relationship between Tlyzed for expression of IL-2, IFNg, IL-4, and with an IgG isotype
control in combination with BrdU. Data are from one representative cell frequency and clonal expansion was preserved. Our
experiment of five with two mice/group/experiment. experimental model employs CD41 T cell precursor fre-
quencies between 0.5% and 50%, both many fold above
normal, and we stimulate the T cells using a high dose
of peptide in saline. The aim of this protocol was tonot higher than, cycling CD41Va111 cells. Nontrans-
genic CD41Va112 cells expressed no INFg. saturate the TCRs of all the TCR transgenic cells, which
appears to be the case based on the changes in cellAs expected and reported by others, the cells that
produced IFNg did not express any IL-4 (Figure 5). Since surface markers and cyclin D3 in all the TCR transgenic
cells. While this is a very contrived system, our conclu-Th1 and Th2 cells are subject to cross-regulation (Riviere
et al., 1998), the abundance of IFNg may explain the sions do not hinge on the similarity of the model to a
normal immune response but on the potential of cellslack of IL-4 in our chimeras. The genetic background
also influences the polarization of CD41 cell responses to differentiate in the absence of turnover.
What limits the Ag-specific clonal expansion of CD41to Th1 or Th2 (Constant et al., 1997), and in our B10.BR
mice, genes in the B10 background would be expected T cells? In vivo T cells at high frequency are probably
under competition for some limiting resource, whichto suppress IL-4 expression (Xiang et al., 1997). Thus,
we were not able to test whether IL-4 secretion is inde- could be access to peptide/MHC-bearing APC, limiting
amounts of growth factors, or a finite physical spacependent of cell division in this model.
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Figure 6. Chemotactic Activity of SLC and ELC Chemokines on Cycling and Noncycling Ag-Specific Cells
Cycling and noncycling CD41Va111 cells generated upon PCC stimulation in chimeras containing 90% of TCR transgenic cells were examined
for their chemotactic response toward SLC and ELC chemokines.
(A) On day 3, cells from PBS (open symbols) or peptide (closed symbols) treated chimeras were subjected to increasing concentration of SLC
(circles) or ELC (squares) in a chemotaxis assay through 5 mm pore transwell filters. The number of migrated transgenic cells were determined
by flow cytometry for 60 s under a constant sheath pressure with appropriate gates on CD41Va111 cells. Results are expressed as the
chemotactic index (see text).
(B) Input and migrated cells toward SLC (1 nM) and ELC (1 nM) were stained with anti-CD4, anti-Va11, anti-Thy1.2, and anti-BrdU. Results
show BrdU verus FSC on gated CD41Va111Thy1.21 cells. The assay was done in triplicate and data are from one representative experiment
of two.
for expansion. DC, the most efficient APC (Levin et al., contradiction with previous work. Although IL-2 expres-
sion was reported to be cell cycle independent, expres-1993; Constant et al., 1995; Ingulli et al., 1997; Inaba et
al., 1998), were the most likely candidate APC, but our sion of effector cytokines such IFNg and IL-4 were re-
ported to be cell cycle dependent (Bird et al., 1998;experiments with Flt-3L exclude a limitation in DC num-
ber. This is not surprising, since a single DC can stimu- Gudmunsdottir et al., 1999). In one model, T cells were
present in vivo at low frequency (1% Ag-specific CD41late many T cells (Knight et al., 1998). Similarly, antigenic
peptide was very unlikely to be limiting in these experi- cells) and all entered cell cycle 3 days after priming, as
shown by a considerable reduction of carboxyfluores-ments, since all Ag-specific CD41 T cells showed evi-
dence of activation. One mechanism that explains the cein diacetate succinimidyl ester (CFSE) intensity on all
cells (Gudmunsdottir et al., 1999). In the other, Th1 andgeneration of activated but undivided CD41 T cells is
the limited availability of space when T cells are at high Th2 cells were all cycling on day 5 after in vitro stimula-
tion, as shown by a considerable reduction of CFSEfrequency.
While space in the lymphoid system is an undefined intensity on all cells (Bird et al., 1998). These data could
have arisen in two ways. First, the cell cycle could actu-concept, this idea has been used to explain the prolifera-
tion of T cells in lymphopenic hosts (Bell et al., 1987; ally control differentiation, as the authors suggested.
Alternatively, cells showing evidence of multiple divisionRocha et al., 1989; Goldrath et al., 1999; Viret et al.,
1999). In an empty immune system, T cell expansion cycles could have been activated first, in which case
their cytokine synthesis could simply reflect the timeoccurred until no more space was available in the T cell
compartment. Our observation that Ag-specific clonal since activation, with the time-dependent induction of
different cytokine genes. The former interpretation isexpansion was inversely proportional to naive CD41 cell
number suggests that CD41 T cells may sense the num- hard to reconcile with our data, while the latter is fully
compatible with it.ber of activated lymphocytes and that this may regulate
the pool of cycling T cells. The different conclusions probably result from a fea-
ture of the experimental models employed. In our model,
all of the T cells undergo TCR ligation and the cells areThe Link between Cycling and Effector Function
not anergized (based on phenotype change [Figure 3]Entry into the cell cycle was proposed to be a necessary
and their synthesis of IL-2 [Figure 5]), yet some in vivostep leading to T cell differentiation (Bird et al., 1998;
constraint causes many to undergo G1 arrest (Figure 4).Getta et al., 1998; Gudmundsdottir et al., 1999). How-
If in culture this constraint did not apply, all fully acti-ever, the data presented here showed that when T cells
vated cells would be expected to divide, and conversely,were activated with specific peptide in vivo, effector
all inadequately stimulated cells would neither dividecytokine expression occurs without constraints im-
posed by the cell cycle. Our results are in apparent nor undergo full activation. In the in vivo experiments
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of Gudmundsdottir et al., the precursor frequency was Proliferation Is Linked to Mobility
Chemokines exhibit potent and selective chemoattrac-low, and the cells are not subject to the same homeo-
static constraints; therefore, all the fully activated cells tant activity on T lymphocytes (Kim et al., 1999). For
instance, SLC and ELC both exert chemotactic activitywere free to divide, in agreement with our experiments
in chimeras with a low frequency of TCR transgenic on lymphocytes through the CCR7 receptor (Salluto et
al., 1998), but the details are controversial. Some datacells. The point of our paper is that at high precursor
frequency, the tight correlation between division and suggest that SLC and ELC attract naive but not activated
T cells (Gunn et al., 1998; Ngo et al., 1998; Potsch etfunction breaks down. We therefore argue that the link
between proliferation and differentiation is not an intrin- al., 1999), while others suggest the opposite (Willimann
et al., 1998; Yoshida et al., 1998; Sallusto et al., 1999).sic property of the cells themselves but a contingent
property of the experimental model. In our experiments, we found that SLC and ELC were
highly active on activated CD41 T cells and preferentiallyThese studies also address the issue of whether there
is a need for cycling prior to the appearance of the on the noncycling cells (Figure 6). This result can be
explained by the labile expression of CCR7 (Sallusto etactivated phenotype. Information on this issue is some-
what contradictory. While CD44 was strongly upregu- al., 1999), which is present on naive T cells, lost after
2–3 days upon differentiation to effector cells, and tran-lated after a single mitosis, the same study showed
changes in CD62L expression that preceded the first siently reacquired following TCR restimulation.
Fluctuations in CCR7 can explain the flexibility of Tcell division (Gudmundsdottir et al., 1999). On the other
hand, expression of CD44 was reported to be unaffected cells to traffic in and out of lymphoid compartments.
Interaction between CCR7 on a T cell (Yoshida et al.,by several cell cycle inhibitors (Bird et al., 1998). Our
experiments show noncycling cells with a fully activated 1997) and its ELC ligand on a DC (Dieux et al., 1998;
Ngo et al., 1998) may stabilize the T cell–APC interaction.phenotype, i.e., elevated CD69, CD44, and CD11a; re-
duced CD62L and CD49d. Integrating these and other Once activated, T cells may downregulate CCR7 expres-
sion and thus acquire the ability to leave the lymphpublished data, we draw the conclusion that cycling and
phenotype changes are not tightly linked. nodes for inflammatory sites. Since cycling CD41 cells
were poorly attracted by SLC and ELC, these cells mayThis interpretation depends on the previous life history
of the TCR transgenic T cells. Could these cells have have downregulated CCR7 expression. However, non-
cycling CD41 cells were preferentially attracted by bothalready undergone activation and cell division prior to
the experiment? We think not, for several reasons. First, chemokines, suggesting expression of high levels of
CCR7. Our results suggest that emigration of activatedthe cells have a fully naive phenotype, as shown by a
direct comparison with nontransgenic T cells in Figure CD41 cells might be a characteristic of cycling cells that
have lost CCR7. Consistent with this idea, Salluto et al.3. Second, in control experiments (data not shown), we
documented that during the repopulation phase in (1999) showed that CCR72 T cells have undergone a
larger number of divisions compared to CCR71 T cells.mixed bone marrow chimeras, TCR transgenic cells in-
corporate BrdU at a lower rate than nontransgenic cells
(in fact, 3% BrdU1 in Va111 cells versus 6% BrdU1 in Concluding Remarks
Va112 cells at 3 weeks after repopulation). Third, this The experiments in this study speak for the functional
interpretation of our data would require that almost half flexibility of CD41 T cells. These cells do not deliver a
of the TCR transgenic cells in a mixed chimera were stereotyped response consisting of activation, prolifera-
nonnaive and had already been programmed to make tion, migration, and the delivery of effector function.
effector cytokines, and it is simply implausible that they Instead, they integrate many different signals, including
could do this without expressing any activation or differ- the frequency of other responding T cells. This integra-
entiation markers. tion allows the cells to undergo massive clonal expan-
Comparison of different in vivo models reveals that sion when they are present at low frequency but allows
the relationship between cell cycle and effector function a subset of them to bypass this option and proceed
is not “all or none.” Many antagonist ligands have been directly to the delivery of effector function if they are
shown to induce cytokine release or killing without prolif- abundant. This nuanced response results in the avail-
eration (Evavold et al., 1993; Jameson and Bevan, 1995). ability of enough effector cells without unnecessary oc-
Conversely, T cells were able to proliferate without ef- cupation of space or consumption of resources.
fector function, since during the reconstitution of
Experimental Procedureslymphopenic hosts, T cells proliferate in response to
low-affinity/self-ligands but without the acquisition of
Antibodiesan effector phenotype (Goldrath et al., 1999). Under con-
The following monoclonal antibodies (mAbs) were used: anti-CD4ditions of chronic infection, activated CD81 T cells
(RM4–5), anti-Va11 (RR8–1), anti-Vb3 (KJ25), anti-Thy 1.2 (53–2.1),
(CD44hiCD691) proliferated but were unable to express anti-CD44 (IM7), anti-CD69 (H1.2F3), anti-CD62-L (MEL-14), anti-
antiviral cytokines such as IFNg. This state of prolifera- CD11a (2D7), anti-CD49d (R1–2), anti-IL-2 (JES6–5H4), anti-IL-
tion without effector function was described under con- 4(11B11), anti-INFg (XMG1.2), anti-IgG1 as an isotype control. These
ditions of CD4 T cell deficiency, while the induction of antibodies were directly coupled to allophycocyanin (APC), phy-
coerythrin (PE), fluorescein isothiocyanate (FITC), or biotin, in whichCD81 T cell effector function required CD4 help (Zajac
case staining was revealed using streptavidin Cychrome (Phar-et al., 1998). Thus, depending on the environments and
Mingen). Unconjugated anti-cyclin A (H-432), anti-cyclin D3 (C-16),conditions of TCR engagement, a T cell is able to inte-
and anti-p21cip-1 (C-19) were revealed with PE-anti-IgG isotype (Santagrate external signals, respond to competition or loss
Cruz). Four-color stained lymph node cells were analyzed using a
of cooperative interactions with other cells, and then FACSCalibur cytometer.
make decisions to proliferate and/or differentiate. Here,
we showed that under conditions of competition due to Mice
high T cell frequency, many CD41 T cells made the Recombination activating gene (Rag)-2-deficient (Shinkai et al.,
1992) mice on the B10.BR background were obtained from Dr. Derekdecision to differentiate without proliferation.
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Sant’Angelo (Yale University, New Haven, CT). TCR transgenic mice, Chemotaxis Assay
Chemotaxis assays were performed as described (Bleul et al., 1996)which express transgenes encoding a Va11, Vb3 TCR specific for
a pigeon cytochrome c (PCC) peptide presented by I-Ek (Kaye et using a polycarbonate transwell with 6.5 mm diameter and 5 mm
pore size (Corning Costar, Acton, MA). For the assay, 106 cells inal., 1989), were obtained from Dr. Kim Bottomly (Yale University)
and then bred to B10.BR or Rag-22/2 (129 3 B10.BR) strains. TCR 100 ml medium were added to the top chamber of the transwell
inserts. The lower chambers contained 0–100 nM SLC (secondarynon-TG AKR/J (Thy1.1) mice were obtained from Jackson Labora-
tories (Bar Harbor, ME). These mice were kept in a specific pathogen lymphoid tissue chemokine; R&D Systems) or ELC (Epstein-Barr
virus–induced molecule 1 ligand chemokine; R&D Systems). Afterfree facility, and all experiments were performed with 8- to 12-week-
old mice. 3 hr, cells that migrated to the lower chamber were pooled from
triplicate wells and stained for cell surface markers (CD4, Thy1.2,
Va11) and BrdU incorporation as described above. The migratedBM Chimeras
cells were enumerated by collecting events for a fixed time (60 s)Rag-2-deficient mice were irradiated (6 Gy) and reconstituted with
on a FACScalibur using uniform flow and acquisition conditions.a total of 107 T cell–depleted bone marrow cells containing different
Relative counts were determined by the chemotactic index:ratios of cells from TCR transgenic and nontransgenic donor mice.
Six groups of chimeric mice were generated containing 0%, 1%,
Chemotactic Index 510%, 50%, 90%, and 100% TCR transgenic bone marrow cells.
Chimeras were studied at 4 weeks posttransfer, which is the time number of migrating CD4
1Va111 cells in response to chemokine
number of migrating CD41Va111 cells in response to medium aloneof optimal lymphoid reconstitution.
To detect a difference in the chemotactic migration of cycling versus
In Vivo Stimulation and Cycling Cell Accumulation noncycling Ag-specific cells, the frequency of BrdU1 cells in the
BM chimeras were i.p. injected once a day for 3 consecutive days starting population was compared with the frequency of BrdU1 cells
(days 0, 1, and 2) with either 100 mg of PCC peptide (Kaye et al., in the cells that migrated through the membrane.
1989) or 10 mg of SEA (Dohlsten et al., 1993). Control mice were
injected with PBS. The PCC 81–103 peptide (IFAGIKKKAERADLI Acknowledgments
AYLKQATAK) was made by the Yale Protein and Nucleic Acid Chem-
istry Facility. SEA was obtained from Toxin Technology, FL. T cell We thank Dr. E. Pamer for comments on the manuscript, Dr. C. Viret
proliferation in vivo was measured using BrdU. PBS-, SEA-, or PCC- and Dr. S. Turley for helpful discussions, Dr. K. Bottomly for the gift
treated BM chimeras were simultaneously treated with i.p. injections of AND mice, and Dr. D. Sant’Angelo for the gift of Rag-22/2 mice.
of 1 mg BrdU (5-bromo-2-deoxyuridine; Sigma) three times a day The work was supported by the National Institues of Health (AI
at 8 hr intervals on days 0, 1, and 2. Analysis was on day 3, the time 37554 and GM 56689).
of maximum accumulation of BrdU1 cells.
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